Vera’s $300M offering; Abeona resubmits treatment for rare skin diseasenews2024-10-29T14:50:05+00:00October 29th, 2024|Endpoints News|
Biogen’s full Ph2 data for IgA nephropathy drug; Sanofi invests in obesity biotechnews2024-10-28T14:41:45+00:00October 28th, 2024|Endpoints News|